BioCryst: Q1 Earnings Snapshot

May 5, 2022 GMT

DURHAM, N.C. (AP) _ BioCryst Pharmaceuticals Inc. (BCRX) on Thursday reported a loss of $74.2 million in its first quarter.

The Durham, North Carolina-based company said it had a loss of 40 cents per share.

The results missed Wall Street expectations. The average estimate of six analysts surveyed by Zacks Investment Research was for a loss of 39 cents per share.

The drugmaker posted revenue of $49.9 million in the period, also missing Street forecasts. Five analysts surveyed by Zacks expected $50.6 million.

BioCryst shares have declined 26% since the beginning of the year. The stock has decreased 7.5% in the last 12 months.


This story was generated by Automated Insights ( using data from Zacks Investment Research. Access a Zacks stock report on BCRX at